AlphaFold predicted structure
PYGL · P06737

Mean pLDDT
92.7/ 100
Very high
847 residues
Confidence breakdown
- Very high(≥ 90)86%
- Confident(70–90)7%
- Low(50–70)6%
- Very low(< 50)2%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
glycogen phosphorylase L
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalGlycogen storage disease
BIALLELIC, autosomal or pseudoautosomalKetotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
+1 more panels — install the extension to see the full list inline on any page.
glycogen storage disease VI
disorder of glycogen metabolism
Glycogen storage disease due to glycogenin deficiency
neurodegenerative disease
colorectal cancer
acute lymphoblastic leukemia
hereditary disease
rectal cancer
glioma
central nervous system cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Glycogen phosphorylase, liver form
Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis
PYGL · P06737

Mean pLDDT
92.7/ 100
Very high
847 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0